About
7.22USD-0.64 -8.14%
Closed • Updated at 01:18 GMT+00:00Market Cap$64.20M
Volume246.8K
Beta-3.57
RSI38.38
Edesa Biotech, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 19 2026
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
May 14 2026
Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results
Mar 31 2026
Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit
Mar 26 2026
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
Feb 24 2026
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study
Recent Videos

Edesa Biotech Surges 32% on Phase 3 Paridiprubart Data at ERA Congress
May 22, 2026

Edesa Biotech Surges 32% on Phase 3 Paridiprubart Data at ERA Congress
May 22, 2026

Top Movers: +600%+ Semis, Biotech & Power Chips 🚀
May 05, 2026

STRONG RECOVERY | EDSA STOCK ANALYSIS | EDESA BIOTECH STOCK
May 02, 2026
Community Chat
Ask AI
Try asking
